Entero Therapeutics logo

Entero Therapeutics Share Price (NASDAQ: ENTO)

$2.25

0.1

(4.65%)

Last updated on

Check the interactive Entero Therapeutics Stock chart to analyse performance

Entero Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.02
    Today's High:$2.25

    Day's Volatility :10.22%

  • 52 Weeks Low:$0.84
    52 Weeks High:$2.78

    52 Weeks Volatility :69.76%

Entero Therapeutics Stock Returns

PeriodEntero Therapeutics IncIndex (Russel 2000)
3 Months
70.38%
0.0%
6 Months
22.95%
0.0%
1 Year
78.57%
0.0%
3 Years
-74.83%
-4.7%

Entero Therapeutics Inc Key Stats

Check Entero Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.15
Open
$2.06
Today's High
$2.25
Today's Low
$2.02
Market Capitalization
$3.4M
Today's Volume
$117.0K
52 Week High
$2.778
52 Week Low
$0.84
Revenue TTM
$0.0
EBITDA
$-4.6M
Earnings Per Share (EPS)
$-11.97
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-24.28%

Stock Returns calculator for Entero Therapeutics Stock including INR - Dollar returns

The Entero Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Entero Therapeutics investment value today

Current value as on today

₹1,88,211

Returns

₹88,211

(+88.21%)

Returns from Entero Therapeutics Stock

₹82,927 (+82.93%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Entero Therapeutics Stock

2400.0%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Entero Therapeutics Shares from India has grown by 2400.0% over the past 30 days, indicating increased transactional activity.

268%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Entero Therapeutics Stock from India on INDmoney has increased by 268% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Entero Therapeutics Stock

Rating
Trend

Entero Therapeutics Share Price Target

What analysts predicted

Upside of 1500.0%

Target:

$36.00

Current:

$2.25

Entero Therapeutics share price target is $36.00, a slight Upside of 1500.0% compared to current price of $2.25 as per analysts' prediction.

Entero Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, ENTO stock has moved up by 10.3%

Entero Therapeutics Technicals Summary

Sell

Neutral

Buy

Entero Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Entero Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Entero Therapeutics Inc logo
70.45%
22.95%
78.57%
-74.83%
-74.83%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Entero Therapeutics Inc

Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It develops Adrulipase, an oral, non-systemic, and biologic capsule that is in Phase 2 clinical trials for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP), as well as a recombinant lipase enzyme that enables the digestion of fats and other nutrients in CF and CP patients with EPI. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida.
Organization
Entero Therapeutics
Employees
2
CEO
Mr. Richard Joel Paolone
Industry
Miscellaneous

Key Management of Entero Therapeutics Inc

NameTitle
Mr. Richard Joel Paolone
CEO & Director
Ms. Anna Skowron
Chief Financial Officer

Important FAQs about investing in ENTO Stock from India :

What is Entero Therapeutics share price today?

Entero Therapeutics share price today is $2.25 as on at the close of the market. Entero Therapeutics share today touched a day high of $2.25 and a low of $2.02.

What is the 52 week high and 52 week low for Entero Therapeutics share?

Entero Therapeutics share touched a 52 week high of $2.78 and a 52 week low of $0.84. Entero Therapeutics stock price today i.e. is closed at $2.25, lower by 19.01% versus the 52 week high.

How to invest in Entero Therapeutics Stock (ENTO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Entero Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Entero Therapeutics Shares that will get you 0.6667 shares as per Entero Therapeutics share price of $2.25 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Entero Therapeutics Stock (ENTO) from India?

Indian investors can start investing in Entero Therapeutics (ENTO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Entero Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Entero Therapeutics share’s latest price of $2.25 as on August 30, 2025 at 1:29 am IST, you will get 4.4444 shares of Entero Therapeutics. Learn more about fractional shares .

What are the returns that Entero Therapeutics has given to Indian investors in the last 5 years?

Entero Therapeutics stock has given -74.83% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?